Latest information on ibrutinib (ibrutinib) market price and medical insurance policies in 2025

Ibrutinib, also known as ibrutinib in China, is an oral BTK tyrosine kinase inhibitor, mainly used to treat certain BB span>Cell malignant tumors, such as chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), etc. In 2025, ibrutinib has been officially launched in China and has been included in the national medical insurance directory, which has greatly improved patients’ medication accessibility and reduced the economic burden.

In the domestic market, the price of ibrutinib is relatively high, with the market price of one box being approximately 8,000 RMB. Since it has been included in medical insurance, patients can enjoy medical insurance reimbursement when purchasing, but the specific reimbursement ratio and self-payment amount vary depending on regional policies. Therefore, patients should consult local hospital pharmacies in a timely manner when purchasing medicines to understand accurate prices and medical insurance-related policies in order to reasonably arrange medication costs.

At the same time, there are various specifications of ibrutinib generic drugs on the overseas market, and the prices are relatively affordable. For example, common specifications include 140mg120 capsules and 140mg112 capsules, and the price is usually around more than one thousand yuan. The ingredients of generic drugs are basically the same as the original drugs, providing patients with an affordable alternative. In addition, the price of the ibrutinib version produced by Bangladesh Beacon is relatively high, about 4,000 yuan per box, but it is still significantly lower than the price of the domestic original drug, and the quality and efficacy are guaranteed.

Overall, the domestic launch of ibrutinib and its inclusion in medical insurance have enabled patients to obtain treatment drugs at a more reasonable price through formal channels. At the same time, the existence of overseas generic drugs also provides patients with more choices. When taking medication, patients should choose the most suitable treatment plan based on their own conditions and doctor's recommendations, as well as factors such as price, medical insurance policies, and drug sources, to ensure the safety and effectiveness of the treatment.

Reference materials:https://www.drugs.com

xa0